Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)

Clinical trial NCT02067767 · COMPLETED

Trial details

NCT number: NCT02067767
Sponsor: Nantes University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2014-02-01
Primary completion: 2015-12-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.